Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2023

Every FDA drug recall initiated in 2023, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,122 recalls, newest first.

Total recalls
1,122
Class I (high risk)
86
Currently ongoing
316
Most recent
Dec 29, 2023
Class I · High risk

FentaNYL citrate PF

Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Ongoing Wrong potency / content Denver Solutions, LLC DBA Leiters Health NDC 71449-072-82 D-0278-2024
Class I · High risk

FentaNYL citrate PF

Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Ongoing Wrong potency / content Denver Solutions, LLC DBA Leiters Health NDC 71449-072-41 D-0277-2024
Class II · Moderate risk

Premier Value Tussin Cough DM

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Ongoing Microbial contamination Seaway Pharma Inc. D-0215-2024
Class III · Low risk

Benzonatate Capsules

Superpotent drug: Assay results were slightly above specification at the time zero point.

Ongoing Wrong potency / content Amerisource Health Services LLC NDC 68084-214-01 D-0257-2024
Class I · High risk

Americaine

Chemical Contamination: presence of benzene

Completed Chemical / undeclared Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company NDC 63736-378-02 D-0236-2024

Recalls by year